Skip to main content
. 2022 Mar 29;12(3):e051285. doi: 10.1136/bmjopen-2021-051285

Table 5.

Procedures and activities during the study period

Screening visit
(V0)
Pre-baseline visit (V1) Baseline visit
(V2)
End of trial visit (V3)
Week 20 to −13 9 to −6 0 10
Visit day 0 1 2 3
Informed consent X
Review of inclusion and exclusion criteria X
Medical history and examination X
Randomisation X*
Registration of medication and adverse events X X X X
Anthropometry
Body weight X X X X
Height X
Waist circumference X X X X
Body composition (DXA) X X
Biological samples
Fasting blood sample X X X
Saliva sample (SNPs) X
Urine sample X X X
Faecal sample X X
Nutritional assessment
Food Frequency Questionnaire X X
3-day dietary records X X
Other measurements
Blood pressure/heart rate X X X
Three factor eating questionnaire X X
Perceived Stress Scale X X
Behavioural questionnaire (by ONMI) X X
Quality of Life questionnaires X X
Diet satisfaction questionnaire (DSat-28) X X
Money spent on food questions X X
Accelerometer (sleep and PA) X X

*Prior to visit.

†At home activity prior to visit.

‡At home activity following the visit.

DXA, dual-energy X-ray absorptiometry; PA, physical activity.